drugset / Trial / NCT03501251
Efficacy and Safety of Ascending Dosages of Moxidectin and Moxidectin-albendazole Against Trichuris Trichiura
Phase 2
Completed
286 enrolled
Swiss Tropical & Public Health Institute
Public Health Laboratory Ivo de Carneri · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The study rationale is to provide evidence on effective doses of moxidectin and/or moxidectin-albendazole in adolescents (16-18 years old) infected with Trichuris trichiura. The study will take place on Pemba Island, Tanzania.
Timeline
- Start
- 2018-07-03
- Primary completion
- 2018-08-11
- Completion
- 2018-08-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Albendazole | Small molecule | 400 mg | — |
| Subject | Moxidectin | Other / unclassified | 8 mg | — |
| Subject | Moxidectin | Other / unclassified | 16 mg | — |
| Subject | Moxidectin | Other / unclassified | 24 mg | — |